Delivery Order SPE2DB22D3501-SPE2DB25FUJ30
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,364.86 firm fixed price contract is for the supply of Clindamycin Phosphate 1% Foam, a prescription medication, with a completion date of June 10, 2024. This order is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Clindamycin Phosphate 1% Foam, 100 gm. The contract has a ceiling value of $6,681.59 and an ultimate completion date of April 26, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563335833 - Clindamycin Phosphate 1% Foam, 50 grams. The contract has a ceiling value of $1,568.55 and an ultimate completion date of January 17, 2024. This is a firm-fixed-price contract without any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This is a delivery order for $1,298.80 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of 4565505380 - Clindamycin Phosphate 1% Foam 100GM, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
This federal contract award, valued at $2,706.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Clindamycin Phosphate 1% Foam, a pharmaceutical product, with a completion date of November 9, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order (SPE2DB22D2005|SPE2DB24FJPL4) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565047902 - Clindamycin Phosphate 1% Foam 50GM. The order has a ceiling value of $1,267.50 and a completion date of July 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,750.74 firm fixed-price delivery order covers the provision of Clindamycin Phosphate 1% Foam in 50 gram containers. The contract has an ultimate completion date of June 15, 2023 and was awarded on June 14, 2023. It does not have a set-aside designation, indicating the contract was competed openly. Amerisourcebergen Drug Corp holds...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,348.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,327,564 units of Clindamycin Phosphate 1% Lotion in 60 mL containers. This order is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Clindamycin Phosphate 1% Lotion, 60ML. The contract has a potential value of $2,239.35 and a period of performance through March 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,888.43 firm fixed-price contract is for the supply of Clindamycin Phosphate 1% gel, a topical antibiotic medication. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA's Troop Support Medical division, valued at $999,999,999 and running through November 2026. The IDC serves as a...